Beijing Hotgen Biotech Co.,Ltd.’s Net Profit Dropped 90.8% in First Half of 2023

Beijing Hotgen Biotech Co.,Ltd. (北京热景生物技术股份有限公司) (688068.SH) reported a net profit of 76.4 million yuan in the first half of 2023, down 90.8% year-on-year.

Meanwhile, the company posted 307 million yuan in revenue, down 85% year-on-year.

At the end of the reporting period, it had 3.7 billion yuan in total assets and 270.6 million yuan in total liabilities, with a liability-to-asset ratio of 7.3%.